Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2024-05-15 History
Report ID 228024
Drug Identification Number 02182777
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL
Packaging size 1 X 5 VIALS
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-08-07
Actual start date
Estimated end date 2024-08-19
Actual end date
Shortage status Anticipated shortage
Updated date 2024-05-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-05-15 English Compare
v2 2024-05-15 French Compare

Showing 1 to 2 of 2